Authored Content
In the latest installment of our RLT series, we explore the manufacturing, supply chain, infrastructure, and workforce challenges shaping access.
Radioligand therapies show benefit across cancers, but US adoption is limited by infrastructure, reimbursement, imaging access, and care coordination gaps